About Enhancer

Enhancer ID: E_02_0143
Species: human
Position : chr7:100717697-100719697
Biosample name:
Experiment class : High+Lowthroughput
Enhancer type: Enhancer
Disease: Vascular calcification
Pubmed ID:  31689455
Enhancer experiment: Western blot,PCR
Enhancer experiment description: EPO prevented the reduction of VSMC phenotypic markers, and reversed the increased calcium content and calcium salt deposition in the aortas of CKD rats and cultured calcified VSMCs.

About Target gene

Target gene : EPO(Epo),EPOR
Strong evidence: qRT-PCR,qPCR,ChIP,3C
Less strong evidence: RNA-Seq
Target gene experiment description: EPO prevented the reduction of VSMC phenotypic markers, and reversed the increased calcium content and calcium salt deposition in the aortas of CKD rats and cultured calcified VSMCs.;The EPO receptor (EPOR) mediates the pleiotropic effects of EPO in target cells

About TF

TF name : --
TF experiment: Western blot,PCR
TF experiment description: EPO prevented the reduction of VSMC phenotypic markers, and reversed the increased calcium content and calcium salt deposition in the aortas of CKD rats and cultured calcified VSMCs.;The EPO receptor (EPOR) mediates the pleiotropic effects of EPO in target cells

About Function

Enhancer function : EPO prevented the reduction of VSMC phenotypic markers, and reversed the increased calcium content and calcium salt deposition in the aortas of CKD rats and cultured calcified VSMCs.
Enhancer function experiment: Immunohistochemical staining
Enhancer function
experiment description:
EPO prevented the reduction of VSMC phenotypic markers, and reversed the increased calcium content and calcium salt deposition in the aortas of CKD rats and cultured calcified VSMCs.

About SNP

SNP ID: --

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs